0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          This Executive Summary of the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017 Report focuses primarily on the revised and novel parts of the document. The most significant changes include: (i) the assessment of chronic obstructive pulmonary disease has been refined to separate the spirometric assessment from symptom evaluation. ABCD groups are now proposed to be derived exclusively from patient symptoms and their history of exacerbations; (ii) for each of the groups A to D, escalation strategies for pharmacological treatments are proposed; (iii) the concept of de-escalation of therapy is introduced in the treatment assessment scheme; (iv)non-pharmacological therapies are comprehensively presented and (v) the importance of co-morbid conditions in managing COPD is reviewed.

          Related collections

          Author and article information

          Journal
          Respirology
          Respirology (Carlton, Vic.)
          Wiley-Blackwell
          1440-1843
          1323-7799
          Apr 2017
          : 22
          : 3
          Affiliations
          [1 ] University of Marburg, Member of the German Center for Lung Research (DZL), Marburg, Germany.
          [2 ] Lewis Katz School of Medicine at, Temple University, Philadelphia, Pennsylvania.
          [3 ] New York-Presbyterian Hospital, Weill Cornell Medical Center, New York, New York.
          [4 ] University of Texas Health Science Center, San Antonio, Texas.
          [5 ] South Texas Veterans Health Care System, San Antonio, Texas.
          [6 ] National Heart and Lung Institute, Imperial College, London, United Kingdom.
          [7 ] McGill University Health Centre, McGill University, Montreal, Quebec, Canada.
          [8 ] Brigham and Women's Hospital, Boston, Massachusetts.
          [9 ] State Key Lab for Respiratory Disease, Guangzhou Institute of Respiratory Disease, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
          [10 ] University of Leuven, Leuven, Belgium.
          [11 ] University of Modena and Reggio Emilia, Modena, Italy.
          [12 ] Faculty of Medicine, Flinders University, Bedford Park, South Australia, Australia.
          [13 ] Royal Devon and Exeter Hospital, Exeter, United Kingdom.
          [14 ] Universidad de la República, Hospital Maciel, Montevideo, Uruguay.
          [15 ] Hokkaido University School of Medicine, Sapporo, Japan.
          [16 ] Hôpital Cochin (Assistance Publique-Hôpitaux de Paris), University Paris Descartes, Paris, France.
          [17 ] Thorax Institute, Hospital Clinic Universitat de Barcelona, Barcelona, Spain.
          [18 ] St. Paul's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
          [19 ] University of Manchester, Manchester, United Kingdom.
          [20 ] University Hospital, Birmingham, United Kingdom.
          [21 ] Hospital Clínic, Universitat de Barcelona, Centro de Investigación Biomé dica en Red de Enfermedade Respiratorias, Barcelona, Spain.
          Article
          10.1111/resp.13012
          28150362

          Comments

          Comment on this article